How did Clue come to acquire DOT’s IP and clinical study?

Clue Birth Control is powered by an algorithm that was developed by researchers at the Institute for Reproductive Health at Georgetown University (IRH). The algorithm was then incorporated into an app called DOT (Dynamic Optimal Timing) and tested in a clinical research study, demonstrating its efficacy.

 

The Clue and DOT teams both strongly believe in providing new evidence-based contraceptive choices for women. As Clue became the pioneering voice of Femtech and a trusted leader in the world of female health, the team behind DOT was looking to find a partner who had the operational capacity to successfully bring DOT to users around the world.

Was this article helpful?
0 out of 0 found this helpful
Have more questions? Submit a request
Powered by Zendesk